27 results on '"Herbert, Andrew S."'
Search Results
2. Two point mutations in protocadherin-1 disrupt hantavirus recognition and afford protection against lethal infection
3. Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38
4. Seroprevalence as an Indicator of Undercounting of COVID-19 Cases in a Large Well-Described Cohort
5. Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread
6. Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies
7. Crimean-Congo Hemorrhagic Fever Survivors Elicit Protective Non-Neutralizing Antibodies that Target 11 Overlapping Regions on Viral Glycoprotein GP38
8. Inflammation in the COVID-19 airway is due to inhibition of CFTR signaling by the SARS-CoV-2 spike protein.
9. SARS-CoV-2 Aerosol and Intranasal Exposure Models in Ferrets
10. Prophylactic Administration of the Monoclonal Antibody Adintrevimab Protects against SARS-CoV-2 in Hamster and Non-Human Primate Models of COVID-19
11. 1143. Prophylactic and Therapeutic Activity of AZD7442 (Tixagevimab/Cilgavimab) in SARS-CoV-2 Hamster Challenge Models
12. Two point mutations in protocadherin-1 disrupt Andes hantavirus recognition and afford protection against lethal infection
13. Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses
14. The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans
15. Antibody Response to SARS-CoV-2 Infection and Vaccination in COVID-19-Naïve and Experienced Individuals
16. Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays
17. A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants
18. Two Distinct Lysosomal Targeting Strategies Afford Trojan Horse Antibodies With Pan-Filovirus Activity
19. AZD7442 demonstrates prophylactic and therapeutic efficacy in non-human primates and extended half-life in humans
20. Characterization of an Anti-Ebola Virus Hyperimmune Globulin Derived From Convalescent Plasma
21. Characterization of an Anti-Ebola Virus Hyperimmune Globulin Derived From Convalescent Plasma.
22. Structural and mechanistic basis of neutralization by a pan-hantavirus protective antibody
23. Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach.
24. Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread.
25. Engineering, structure, and immunogenicity of a Crimean-Congo hemorrhagic fever virus pre-fusion heterotrimeric glycoprotein complex.
26. Crimean-Congo Hemorrhagic Fever Survivors Elicit Protective Non-Neutralizing Antibodies that Target 11 Overlapping Regions on Viral Glycoprotein GP38.
27. A novel compound active against SARS-CoV-2 targeting uridylate-specific endoribonuclease (NendoU/NSP15): in silico and in vitro investigations.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.